Can I read Biosimilars 101 on EtoBox?
Biosimilars 101 by Ben Patton is a document available to read on EtoBox.
What is Biosimilars 101 about?
Biosimilars are safe and effective therapeutics derived from biologic drugs that offer significant cost savings and expanded patient access to treatments for complex diseases like diabetes, arthritis, and cancer. They are rigorously tested for safety and efficacy, ensuring they provide comparable clinical benefits to their reference products. The introduction of biosimilars is projected to save the U.S. healthcare system up to $250 billion by 2024, fostering competition and enabling access to innovative the
- Author
- Ben Patton
- Language
- EN